[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: EPA, risk and dose
- --part1_11.11eeb2aa.27f67ad2_boundary
Content-Type: text/plain; charset="US-ASCII"
Content-Transfer-Encoding: 7bit
In a message dated 03/30/2001 6:20:01 AM Pacific Standard Time,
Eric.Frohmberg@state.me.us writes:
> I faxed you a few pages - including a table discussing the differences.
Thank you. I received it, and will look it over, especially the comparison
table.
> I'm unconvinced that EPA really believes that you CAN'T convert dose to risk
> - one CAN and they've done it before. It may have been a poor choice of
>
I think you are right. I think that the Q&A I was looking at was a little
mis-leading. I've re-evaluated what they're saying and they are willing to
convert dose to risk on a pathway/nuclide specific basis. What I think they
are trying to avoid is taking an all pathway TEDE and THEN applying a risk
factor. I still contend that if one accepts the ICRP normalization of dose,
then you should be able to do that, but that appears to be what EPA is
rejecting.
Barbara L. Hamrick
BLHamrick@aol.com
- --part1_11.11eeb2aa.27f67ad2_boundary
Content-Type: text/html; charset="US-ASCII"
Content-Transfer-Encoding: 7bit
<HTML><FONT FACE=arial,helvetica><FONT SIZE=2>In a message dated 03/30/2001 6:20:01 AM Pacific Standard Time,
<BR>Eric.Frohmberg@state.me.us writes:
<BR>
<BR>
<BR><BLOCKQUOTE TYPE=CITE style="BORDER-LEFT: #0000ff 2px solid; MARGIN-LEFT: 5px; MARGIN-RIGHT: 0px; PADDING-LEFT: 5px">I faxed you a few pages - including a table discussing the differences.</FONT><FONT COLOR="#000000" SIZE=3 FAMILY="SANSSERIF" FACE="Arial" LANG="0"></BLOCKQUOTE>
<BR>
<BR></FONT><FONT COLOR="#000000" SIZE=2 FAMILY="SANSSERIF" FACE="Arial" LANG="0">Thank you. I received it, and will look it over, especially the comparison
<BR>table.
<BR></FONT><FONT COLOR="#000000" SIZE=3 FAMILY="SANSSERIF" FACE="Arial" LANG="0">
<BR></FONT><FONT COLOR="#000000" SIZE=2 FAMILY="SANSSERIF" FACE="Arial" LANG="0"><BLOCKQUOTE TYPE=CITE style="BORDER-LEFT: #0000ff 2px solid; MARGIN-LEFT: 5px; MARGIN-RIGHT: 0px; PADDING-LEFT: 5px">I'm unconvinced that EPA really believes that you CAN'T convert dose to risk
<BR>- one CAN and they've done it before. It may have been a poor choice of
<BR>words on their part.</BLOCKQUOTE>
<BR>
<BR>I think you are right. I think that the Q&A I was looking at was a little
<BR>mis-leading. I've re-evaluated what they're saying and they are willing to
<BR>convert dose to risk on a pathway/nuclide specific basis. What I think they
<BR>are trying to avoid is taking an all pathway TEDE and THEN applying a risk
<BR>factor. I still contend that if one accepts the ICRP normalization of dose,
<BR>then you should be able to do that, but that appears to be what EPA is
<BR>rejecting.
<BR>
<BR>Barbara L. Hamrick
<BR>BLHamrick@aol.com</FONT></HTML>
- --part1_11.11eeb2aa.27f67ad2_boundary--
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.
------------------------------